| Daily aspirin use associated with reduced risk for fibrosis progression in patients with nonalcoholic fatty liver disease TG Simon, J Henson, S Osganian, R Masia, AT Chan, RT Chung, ... Clinical Gastroenterology and Hepatology 17 (13), 2776-2784. e4, 2019 | 144 | 2019 |
| Advanced fibrosis is associated with incident cardiovascular disease in patients with non‐alcoholic fatty liver disease JB Henson, TG Simon, A Kaplan, S Osganian, R Masia, KE Corey Alimentary pharmacology & therapeutics 51 (7), 728-736, 2020 | 136 | 2020 |
| The association of hepatitis C infection with the onset of CKD and progression into ESRD JB Henson, ME Sise Seminars in dialysis 32 (2), 108-118, 2019 | 32 | 2019 |
| Complementary and alternative medicine use in United States adults with liver disease JB Henson, CL Brown, SC Chow, AJ Muir Journal of clinical gastroenterology 51 (6), 564-570, 2017 | 32 | 2017 |
| Outcomes of liver retransplantation in patients with primary sclerosing cholangitis JB Henson, YA Patel, LY King, J Zheng, SC Chow, AJ Muir Liver Transplantation 23 (6), 769-780, 2017 | 31 | 2017 |
| Risk of cardiovascular disease in individuals with nonobese nonalcoholic fatty liver disease A Arvind, JB Henson, SA Osganian, C Nath, LM Steinhagen, ZN Memel, ... Hepatology Communications 6 (2), 309-319, 2022 | 18 | 2022 |
| Evaluation of the potential utility of an artificial intelligence chatbot in gastroesophageal reflux disease management JB Henson, JRG Brown, JP Lee, A Patel, DA Leiman Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 16 | 2022 |
| Is nonalcoholic fatty liver disease not a risk factor for cardiovascular disease: not yet time for a change of heart JB Henson, M Roden, G Targher, KE Corey Hepatology 71 (5), 1867-1869, 2020 | 15 | 2020 |
| Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons with HIV A Kaplan, TG Simon, JB Henson, T Wang, H Zheng, SA Osganian, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 84 (4), 400-404, 2020 | 14 | 2020 |
| Access to technology to support telehealth in areas without specialty care for liver disease JB Henson, K Wegermann, YA Patel, JM Wilder, AJ Muir Hepatology 77 (1), 176-185, 2023 | 13 | 2023 |
| Trends in statin utilisation in US adults with non‐alcoholic fatty liver disease JB Henson, YA Patel, AJ Muir Alimentary Pharmacology & Therapeutics 54 (11-12), 1481-1489, 2021 | 13 | 2021 |
| Transplant outcomes in older patients with nonalcoholic steatohepatitis compared to alcohol-related liver disease and hepatitis C JB Henson, JM Wilder, MR Kappus, AS Barbas, CA Moylan, ... Transplantation 104 (6), e164-e173, 2020 | 13 | 2020 |
| The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and … YA Patel, JB Henson, JM Wilder, J Zheng, SC Chow, CL Berg, ... Clinical transplantation 32 (10), e13388, 2018 | 13 | 2018 |
| Differences in phenotypes and liver transplantation outcomes by age group in patients with primary sclerosing cholangitis JB Henson, YA Patel, JM Wilder, J Zheng, SC Chow, LY King, AJ Muir Digestive diseases and sciences 62, 3200-3209, 2017 | 13 | 2017 |
| Social determinants of health data in solid organ transplantation: national data sources and future directions NW Chan, M Moya-Mendez, JB Henson, H Zaribafzadeh, MP Sendak, ... American Journal of Transplantation 22 (10), 2293-2301, 2022 | 10 | 2022 |
| Characterization of social determinants of health of a liver transplant referral population JB Henson, NW Chan, JM Wilder, AJ Muir, LM McElroy Liver Transplantation 29 (11), 1161-1171, 2023 | 9 | 2023 |
| Rates of employment after liver transplant: A nationwide cohort study JB Henson, M Cabezas, LM McElroy, AJ Muir Hepatology Communications 7 (3), e0061, 2023 | 4 | 2023 |
| Evaluation of an abnormal liver panel after liver transplantation JB Henson, AJ Muir Clinics in liver disease 27 (1), 103-115, 2023 | 4 | 2023 |
| Patient-predicted outcomes are associated with quality of life in patients with primary sclerosing cholangitis JB Henson, JH Helzberg, AJ Muir Digestive Diseases and Sciences 67 (12), 5483-5492, 2022 | 4 | 2022 |
| Post-transplant management and complications of autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis including disease recurrence JB Henson, LY King Clinics in liver disease 28 (1), 193-207, 2024 | 2 | 2024 |
